Chronic Low Back Pain Clinical Trial
Official title:
Correction of Abnormal Flexion-relaxation Phenomenon in Chronic Low Back Pain: the Benefit Associated With Biofeedback Training
Verified date | July 2015 |
Source | Université du Québec à Trois-Rivières |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Interventional |
The purpose of the present study is to evaluate the benefit of biofeedback training on the capacity of chronic low back pain patients to decrease their lumbar paraspinal muscles activity during trunk full flexion and its relationship with changes in clinical outcomes. To do so, twenty patients with nonspecific mechanical low back pain will be recruited and all participants will take part in four sessions of supervised biofeedback training, consisting of 5 blocks with at least 12 trunk flexion-extension tasks. It is hypothesized that participants will have improved neuromechanical parameters with the biofeedback training and that this improvement will be positively associated to changes in clinical outcomes. This study will also allow for generation of preliminary data, in order to plan for a larger randomized control trial.
Status | Completed |
Enrollment | 21 |
Est. completion date | November 2014 |
Est. primary completion date | September 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Being between 18 and 60 years of age. - Presence of non-specific chronic low back pain. Exclusion Criteria: - Prior surgery or major spine trauma. - Lumbar scoliosis greater than 20°. - Neuromuscular disease. - Malignant tumor. - Uncontrolled hypertension. - Infection. - Neurological deficit. - Symptomatic lumbar disc herniation. - Pregnancy. - Recent lumbar cortisone injection. - Active lower body injury and/or disabling pain limiting the capacity to complete the experimentation. - Being under medications known to impair physical effort and pain perception. |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | Université du Québec à Trois-Rivières | Trois-Rivières | Quebec |
Lead Sponsor | Collaborator |
---|---|
Université du Québec à Trois-Rivières |
Canada,
Demoulin C, Crielaard JM, Vanderthommen M. Spinal muscle evaluation in healthy individuals and low-back-pain patients: a literature review. Joint Bone Spine. 2007 Jan;74(1):9-13. Epub 2006 Nov 13. Review. — View Citation
Frank DL, Khorshid L, Kiffer JF, Moravec CS, McKee MG. Biofeedback in medicine: who, when, why and how? Ment Health Fam Med. 2010 Jun;7(2):85-91. — View Citation
Giggins OM, Persson UM, Caulfield B. Biofeedback in rehabilitation. J Neuroeng Rehabil. 2013 Jun 18;10:60. doi: 10.1186/1743-0003-10-60. Review. — View Citation
Hodges PW. Pain and motor control: From the laboratory to rehabilitation. J Electromyogr Kinesiol. 2011 Apr;21(2):220-8. doi: 10.1016/j.jelekin.2011.01.002. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Flexion-relaxation Ratio | Flexion-relaxation ratio is calculated by dividing muscle activity (EMG) during trunk flexion by muscle activity during full-flexed position. EMG of lumbar paraspinal muscles is recorder through surface EMG during every trials of each session. | Week 1 | No |
Primary | Flexion-relaxation Ratio | Flexion-relaxation ratio is calculated by dividing muscle activity (EMG) during trunk flexion by muscle activity during full-flexed position. EMG of lumbar paraspinal muscles is recorder through surface EMG during every trials of each session. | Week 2 | No |
Primary | Flexion-relaxation Ratio | Flexion-relaxation ratio is calculated by dividing muscle activity (EMG) during trunk flexion by muscle activity during full-flexed position. EMG of lumbar paraspinal muscles is recorder through surface EMG during every trials of each session. | Week 3 | No |
Primary | Flexion-relaxation Ratio | Flexion-relaxation ratio is calculated by dividing muscle activity (EMG) during trunk flexion by muscle activity during full-flexed position. EMG of lumbar paraspinal muscles is recorder through surface EMG during every trials of each session. | Week 4 | No |
Secondary | Lumbo-pelvic Range of Motion During Trunk Flexion-extension | Range of motion is recorder throught 8 kinematic markers placed on the right lower limb and the back of each participant during every trials of each session. | Week 1 | No |
Secondary | Disability Level | Oswestry disability index ranges from 0 to 100. A higher score indicates higher disability. | Week 4 | No |
Secondary | Pain Intensity in the Past Week | 101-points numerical rating scale that ranges from 0 (no pain) to 100 (worst possible pain). | Week 2 | No |
Secondary | Current Pain Intensity | 101-points numerical rating scale that ranges from 0 (no pain) to 100 (worst possible pain). | Week 3 | No |
Secondary | Fear of Movement Level | Tampa scale for kinesiophobia ranges from 0 to 68. Higher score indicates higher fear of movement level. | Week 4 | No |
Secondary | Current Pain Intensity | 101-points numerical rating scale that ranges from 0 (no pain) to 100 (worst possible pain). | Week 2 | No |
Secondary | Current Pain Intensity | 101-points numerical rating scale that ranges from 0 (no pain) to 100 (worst possible pain). | Week 4 | No |
Secondary | Pain Intensity in the Past Week | 101-points numerical rating scale that ranges from 0 (no pain) to 100 (worst possible pain). | Week 3 | No |
Secondary | Pain Intensity in the Past Week | 101-points numerical rating scale that ranges from 0 (no pain) to 100 (worst possible pain). | Week 4 | No |
Secondary | Lumbo-pelvic Range of Motion During Trunk Flexion-extension | Range of motion is recorder throught 8 kinematic markers placed on the right lower limb and the back of each participant during every trials of each session. | Week 2 | No |
Secondary | Lumbo-pelvic Range of Motion During Trunk Flexion-extension | Range of motion is recorder throught 8 kinematic markers placed on the right lower limb and the back of each participant during every trials of each session. | Week 3 | No |
Secondary | Lumbo-pelvic Range of Motion During Trunk Flexion-extension | Range of motion is recorder throught 8 kinematic markers placed on the right lower limb and the back of each participant during every trials of each session. | Week 4 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |